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Cell fate acquisition is heavily influenced by direct
interactions between master regulators and tissue-
specific enhancers. However, it remains unclear
how lineage-specifying transcription factors, which
are often expressed in both progenitor and mature
cell populations, influence cell differentiation. Using
in vivo mouse liver development as a model, we
identified thousands of enhancers that are bound
by the master regulators HNF4A and FOXA2 in a
differentiation-dependent manner, subject to chro-
matin remodeling, and associated with differentially
expressed target genes. Enhancers exclusively
occupied in the embryo were found to be responsive
to developmentally regulated TEAD2 and coactivator
YAP1. Our data suggest that Hippo signaling may
affect hepatocyte differentiation by influencing
HNF4A and FOXA2 interactions with temporal en-
hancers. In summary, transcription factor-enhancer
interactions are not only tissue specific but also
differentiation dependent, which is an important
consideration for researchers studying cancer bio-
logy or mammalian development and/or using trans-
formed cell lines.INTRODUCTION
The recent generation of induced hepatocytes from both mouse
and human fibroblasts via ectopic expression of transcription
factors (TFs), Hepatocyte nuclear factor 1 or 4 alpha (HNF1/
4A), and Forkhead box A2 or 3 (FOXA2/3) in fibroblasts highlights
how critical our understanding of TF biology and in vivo hepato-
cyte differentiation is for the advancement of alternative liver dis-
ease therapies (Du et al., 2014; Huang et al., 2011; Huang et al.,2014; Sekiya and Suzuki, 2011; Simeonov and Uppal, 2014). It is
well established that lineage-specifying TFs determine cell fate
through interactions with tissue-specific enhancers. However,
it is not clear how master regulators, expressed in both embry-
onic and adult liver, coordinate the gene-expression changes
that are necessary for organ formation and mature hepatocyte
cell function.
The adult liver is primarily composed of hepatocytes, the prin-
cipal functional cell of the liver. This relative homogeneity has
made it an ideal tissue for numerous historic gene-regulation
studies. In contrast, the embryonic liver is home to a large
population of hematopoietic precursors, which has previously
hampered investigation of transcriptional regulation in hepato-
cyte progenitors, known as hepatoblasts. Hepatoblasts are
bipotential cells that during development progressively differen-
tiate into hepatocytes and cholangiocytes (bile duct cells).
Maturing hepatocytes begin to express genes that control meta-
bolism and detoxification, and produce serum proteins, bile, and
hormones. It is notoriously difficult to maintain mature hepato-
cyte gene-expression profiles and cell functions in vitro (Raju
et al., 2013), and consequently the role of TFs in hepatocyte dif-
ferentiation and function is best demonstrated by in vivo studies.
Embryos devoid of HNF4A fail to reach gastrulation due to
defects in the visceral endoderm. Early lethality can be rescued
by provision of wild-type extraembryonic tissue via a tetraploid
methodology (Duncan et al., 1997). In this context, liver specifi-
cation occurs in Hnf4a null embryos; however, hepatocyte pre-
cursors fail to differentiate (Parviz et al., 2003). A later depletion
of HNF4A by 6 weeks postpartum results in disrupted liver archi-
tecture; changes in serum, lipid, and urea levels; and ultimately a
70% mortality rate by 8 weeks of age (Hayhurst et al., 2001).
Members of the Forkhead box, subfamily A, of TFs (FOXA1/2/
3) have been shown to play major roles in animal development.
Foxa2 null mice fail to form regions of definitive endoderm that
give rise to liver (Lee et al., 2005), and conditional Foxa2 deletion
in late fetal hepatocytes causes sensitivity to a cholic-acid-
containing diet, triggering a toxic accumulation of bile salts,
endoplasmic reticulum stress, and liver injury (Bochkis et al.,Cell Reports 9, 261–271, October 9, 2014 ª2014 The Authors 261
Figure 1. HNF4A and FOXA2 ChIP-Seq in
Purified Fetal Hepatoblasts
(A) Immunofluorescence analysis of cryosectioned
mouse embryos at E14.5, showing colabeling of
hepatoblastswith thecell-surfacemarkerdelta-like-
1(DLK1, green), hepatic nuclear factor 4a (HNF4A,
red) and nuclei (DAPI, blue). Scale bar, 100 mm.
(B) Venn diagram representing the number of
called peaks (FindPeaks, FDR < 0.01) for FOXA2
(white) and HNF4A (black) in hepatoblast ChIP-seq
data sets. Peaks with >50 bp shared FOXA2 and
HNF4A were considered to be common sites of
enrichment (gray).
(C) GO enrichment analysis of shared target genes
Selected statistically significant enriched path-
ways are shown and graphed using the binomial
log10 p value on the y axis.
(D) Read density histograms represent the
enrichment of HNF4A and FOXA2 detected by
ChIP-seq in embryonic hepatoblasts proximal to
the hepatoblast biomarkers Gpc3 and Dlk1.
See also Figure S1 and Table S1.2009). FOXAs have a structural similarity to linker histones and
are able to bind condensed chromatin, where they can either
passively act as placeholders for recruitment of factors later in
development or actively recruit other factors for transcriptional
initiation (Sekiya et al., 2009; Zaret and Carroll, 2011). Despite
their pioneer function, FOXA TFs have previously been shown
to bind different target sites in diverse cell lines and tissues
that affect distinct gene-expression repertoires (Lupien et al.,
2008). Furthermore, cooperation with nuclear hormone receptor
family members, namely, the estrogen and androgen receptors,
has been shown to influence binding-site choice and account
for gender-dependent susceptibility to hepatocellular carcinoma
(Li et al., 2012).
Although it has been clearly demonstrated that HNF4A and
FOXA2 are necessary for both acquisition of hepatoblast cell
fate and maintenance of mature hepatocyte function, it is not
yet understood how stably expressed TFs are able to fulfill
such distinct roles during organ maturation. We hypothesized
that identifying and comparing target genes in hepatoblasts
and hepatocytes would enable us to better understand how
these master regulators contribute to hepatocyte differentiation.
Here, we show that HNF4A and FOXA2 interact with thousands
of enhancer regions in a differentiation-dependent manner
to orchestrate gene-expression changes required for liver devel-
opment. Our data uncover how developmentally regulated
enhancer switching is affected by Hippo signaling. We propose
that dynamic TF-DNA binding may represent a common mech-
anism by which master regulators control the process of organ
maturation during mammalian development.
RESULTS
Widespread Combinatorial Role for HNF4A and FOXA2
in the Embryonic Liver
To gain a detailed understanding of how HNF4A and FOXA2
cooperate and interact with cis-regulatory elements during hep-
atoblast maturation in vivo, we performed a chromatin immuno-262 Cell Reports 9, 261–271, October 9, 2014 ª2014 The Authorsprecipitation followed by next-generation sequencing (ChIP-
seq) analysis on hepatoblasts from fetal liver at embryonic day
14.5 (E14.5). We purified hepatoblasts from resident hematopoi-
etic cells by magnetic-activated cell sorting using a previously
characterized hepatoblast marker, Delta-like 1 (DLK1) (Tanimizu
et al., 2003; Wei et al., 2013), which is found on the surface of
HNF4A/FOXA2-positive cells in the liver at E14.5 (Figures 1A
and S1). We sequenced DNA immunoprecipitated by HNF4A
or FOXA2 antibodies (as described in Experimental Proce-
dures), and identified a total of 11,703 HNF4A-bound and
9,398 FOXA2-bound regions (based on a false-discovery rate
[FDR] of 0.01 to determine peak height thresholds) in the fetal
liver (Table S1).
Since regions bound bymultiple TFs aremore likely to function
as tissue-specific enhancers (Hoffman et al., 2010), we deter-
mined the extent and location of HNF4A and FOXA2 colocali-
zation prior to hepatocyte maturation. Approximately 30%
of FOXA2 binding was found to occur at HNF4A-occupied sites
(Figure 1B). Sites of coenrichment, like the majority of all HNF4A
and FOXA2 sites, were frequently found within distal intergenic
regions (Figure S1; Shin et al., 2009). Due to the remote location
of many TF-binding sites, we associated cis-regulatory regions
with target genes using previously established enhancer and
promoter units and conducted a Gene Ontology (GO) analysis
(Ashburner et al., 2000; Shen et al., 2012). This identified 2,957
genes as putative direct targets. Many genes were found to
associate with processes integral to hepatocyte function, such
as the lipid metabolic process (binominal p value = 4.53 1048).
Other target loci included TFs such as Prox1, Cited2, and
Onecut1/2, which are linked to liver development (p = 1.01 3
10102), cell number homeostasis (p = 1.10 3 1039), integrin-
mediated signaling pathway regulation (p = 1.5 3 1042), and
actin cytoskeleton organization (p = 3.47 3 10169). Examples
of shared HNF4A and FOXA2 binding events in embryonic liver
are shown in Figure 1D for Gpc3 (top) and Dlk1 (bottom), both
of which are associated with a hepatoblast cellular phenotype
(Grozdanov et al., 2006; Tanimizu et al., 2003).
Figure 2. HNF4A and FOXA2 Co-occupy
Target Sites in a Differentiation-Dependent
Manner
(A) Read density histograms proximal to the Afp
(left) and Prlr (right) locus, displaying HNF4A
and FOXA2 ChIP-seq data sets generated from
embryonic hepatoblasts (green) and adult hepa-
tocytes (blue).
(B) Venn diagram representing regions of enrich-
ment in embryonic (green) and adult (blue) ChIP-
seq data sets for HNF4A and FOXA2. Sites with
>50 bp overlap between them were designated
as common between data sets (gray).
(C) ChIP-qPCR verification of sites defined as
embryonic (green bar) or adult (blue bar); data are
represented as mean ± SEM from duplicate
experiments.
(D) Heatmap representation of TF enrichment
(black, high; gray, low) at all regions bound by
both HNF4A and FOXA2 during at least one stage
of liver development. Enrichment levels were pro-
filed ±1 kb at a resolution of 50 bp from the peak
center using SitePro in Galaxy/Cistrome toolbox.
Boxes overlaying the heatmap highlight regions
that were selected for further analysis and classi-
fied as embryonic only (green), continuous (gray),
or adult only (blue).
See also Figure S2.HNF4A and FOXA2Bind theGenome in aDifferentiation-
Dependent Manner
To date, gene regulation in the embryonic liver has largely been
examined on a locus-by-locus basis. For example, the regulatory
domains for Alpha-fetoprotein (Afp), an established fetal liver
biomarker, have been extensively studied (Godbout et al.,
1988). A comparison of data from our genomic analysis of
HNF4A and FOXA2 (Figure 2A) with the positions of enhancer re-
gions previously shown to control transcription at theAfp locus in
embryonic liver (E1 2.25 to 2.5 kb, E2 4.9 to 5.1 kb,
E3 6.25 to 6.65 kb; black lines below the histogram) showed
a remarkable correlation (Figure 2A). Furthermore, when we
examined this locus using adult liver HNF4A and FOXA2 ChIP-
seq data sets previously published by our group (Hoffman
et al., 2010; Figure 2A), we confirmed that HNF4A and FOXA2
binding was lost at many of the Afp-associated regulatory re-
gions upon hepatocyte differentiation. One site (indicated in
gray) was occupied in both the embryonic and adult liver. In
contrast, Prlr, which is associated with insulin regulation in the
adult liver, was found to be targeted by HNF4A and FOXA2
exclusively in our adult data sets (Figure 2A).
To establish the extent to which liver maturation is accompa-
nied by changes in HNF4A and FOXA2 binding on a genome-
wide scale, we compared ChIP-seq profiles for HNF4A and
FOXA2 embryonic and adult livers. A comparison of four data
sets gave rise to 15 different types of enrichment profiles
(Figure S2). A remarkable 55% of HNF4A-binding sites were
uniquely occupied in either the embryonic or adult state,
suggesting that these sites are regulated in a differentiation-dependent manner. FOXA2 also altered 60% of its DNA inter-
action sites during liver development (Figure 2B). This global
switch of DNA-binding sites was unexpected and distinct
from situations in which a TF binds only high-affinity sites in
one cell type but both high- and low-affinity sites in another
cell type.
To eliminate the possibility that these binding-site differences
were simply artifacts that arose from the comparison of
historic data sets with new ones, differential data processing,
or imposed height cutoff thresholds, we used unthresholded
data to profile the read enrichment of the HNF4A and FOXA2
data sets within 1 kb of differentially bound sites using SitePro
within the Galaxy/Cistrome toolbox (Shin et al., 2009). We found
no evidence to suggest that TF enrichment was artificially
masked by imposed height cutoffs or that the TFs were binding
to alternative sites in close proximity, confirming that we had
identified differentiation-dependent regions of TF-DNA interac-
tions (Figure 2D). In addition, to experimentally validate our
finding, we carried out four biologically replicated ChIP quantita-
tive PCR (ChIP-qPCR) experiments on 24 sites that showed
distinct patterns of enrichment in our ChIP-seq data sets (Fig-
ure 2C). Cdkn1c, Cit, Dlk1, Sall4, Gpc3, H19, Hmga2, Igf2,
Igf2bp3, Klf7, Mycn, and Zfhx3 showed enriched binding of
both HNF4A and FOXA2 in our embryonic, but not adult, ChIP-
seq data sets. In contrast, enhancers associated with the
genes Agxt, Apoa5, Cml2, Cyp2c29, Gnmt, Ido2, Igf1, Nnmt,
Prlr, Rfx4, Serpina3k, and Fbp1 showed enrichment in our
adult ChIP-seq HNF4A and FOXA2 data. Thus, differentiation-
dependent TF binding occurs during liver development.Cell Reports 9, 261–271, October 9, 2014 ª2014 The Authors 263
Figure 3. Differentiation-Dependent Bind-
ing Sites Show Distinct Patterns of
Enhancer-Associated H3K4me1
(A) Heatmap representation of H3K4me1 at re-
gions bound by both HNF4A and FOXA2 (:) in
embryonic liver only (green, left), both embryonic
and adult liver (gray, middle), or adult liver only
(blue, right). Enrichment levels (white, low; black,
high) were profiled ±1 kb at a resolution of 10 bp
from the TF peak center, represented by the small
black triangle. The vertical ordering of sites is
random.
(B) Average enrichment profiles of H3K4me1 at
differentiation-dependent HNF4A and FOXA2
binding sites (green line, embryo; gray line,
continuous; blue line, adult).
(C) Read density histograms proximal to the BMP7
locus, displaying HNF4A and FOXA2 ChIP-seq
data sets generated from embryonic hepatoblasts
(green), and HNF4A, FOXA2, H3K27me3, and
H3K9me3 ChIP-seq data sets generated from
adult hepatocytes (blue).
(D) Percentage of differentiation-dependent bind-
ing sites showing >2 average read enrichment for
repressive histone modifications H3K27me3 or
H3K9me3 within 2 kb regions surrounding TF-
binding sites.
See also Figure S3.Differentiation-Dependent Binding Sites Function
as Temporal Enhancers
Genomic regions occupied by more than one TF have previously
been shown to associate with tissue-specific gene expression
(Hoffman et al., 2010). Consequently, to better understand the
biological relevance and mechanisms underlying differentia-
tion-dependent DNA binding, we interrogated regions in which
both TFs were gained, lost, or maintained during development.
We categorized sites as embryonic (HNF4A and FOXA2 enrich-
ment in embryonic data sets only [891 sites]), continuous
(HNF4A and FOXA2 enrichment in all data sets [1,050 sites]),
or adult (HNF4A and FOXA2 enrichment in adult data sets only
[1,094 sites]; Figure 2D). Previous studies suggested that higher
levels and a bimodal distribution pattern of monomethylated
histone 3 lysine 4 (H3K4me1) correlate with enhancer function
(Hoffman et al., 2010; Rada-Iglesias et al., 2011). To determine
the activity of identified putative enhancer regions, we measured
H3K4me1 at differentiation-dependent binding sites using our
H3K4me1 ChIP-seq data set generated from adult liver (Hoff-
man et al., 2010). Figure 3A shows a heatmap in which the levels
of H3K4me1 surrounding each target site (±1 kb) are repre-
sented. We observed that regions occupied at both stages of
differentiation (continuous) or exclusively in the adult showed
the highest levels of H3K4me1 at each side of the central TF
binding-site position with a central depletion in signal (a bimodal
pattern). In contrast, embryonic sites that were no longer bound
in the adult showed the highest levels of H3K4me1 in a central
position (a monomodal pattern; Figure 3A). Moreover, the overall
level of H3K4me1 was reduced in the embryonic sites (Fig-
ure 3B). These patterns were also observed in a ChIP-seq anal-
ysis on adult perfused liver using a pan-acetylated H4 antibody
(Figure S3).264 Cell Reports 9, 261–271, October 9, 2014 ª2014 The AuthorsTo determine whether embryonic-specific TF-binding sites are
masked in adult liver via chromatin compaction, we measured
the enrichment patterns of the repressive histone modifications
H3K27me3 and H3K9me3 using ChIP-seq. We found that only
a few embryonic enhancers were enriched for H3K27me3
and H3K9me3 in the adult liver (3% and 7%, respectively), an
example of which is shown in Figure 3C. Furthermore, an anal-
ysis of publically available DNase I hypersensitivity data (Shen
et al., 2012) confirmed that >60% of embryonic sites remain
accessible in the adult liver (data not shown). Together, these
data suggest that enhancer switching is not simply a conse-
quence of Polycomb-mediated chromatin compaction. This
finding is consistent with the established role of FOXA2 as a
pioneer factor that is able to bind compacted nucleosomes. In
summary, our results show that H3K4me1 and H4ac signatures
are distinct at differentiation-dependent binding sites, and
further support the existence of widely dispersed, developmen-
tally regulated, functional enhancers that are differentially bound
by HNF4A and FOXA2 in the liver.
We next investigated the impact of temporal TF-DNA binding
on associated target gene transcription by using RNA sequenc-
ing (RNA-seq) to profile the transcriptomes of both DLK1+
hepatoblasts and adult liver (Table S2). We used alternative
expression analysis by sequencing (ALEXA-seq) (Griffith et al.,
2010) to identify differentially expressed transcripts. More than
2,000 transcripts were enriched in adult hepatocytes compared
with embryonic precursors (Embryo < Adult; Figure 4A), whereas
more than 4,000 genes were more highly expressed in embry-
onic hepatoblasts (Embryo > Adult; Figure 4A). Histograms
of the top-ranking differentially expressed transcripts, H19
(Embryo) and Serpina3K (Adult), are shown as examples in Fig-
ure 4B. To identify the most differentially expressed pathways,
Figure 4. Differential Gene Expression dur-
ing Hepatocyte Maturation Is Associated
with Differentiation-Dependent HNF4A and
FOXA2 Binding
(A) Representation of transcriptome proportions
subject to differential regulation (>2-fold difference
with a Pearson correlation of <0.05), alternative
transcription (inclusion of different exons and/or
untranslated regions) in embryonic hepatoblasts
(green) and adult hepatocytes (blue), or consistent
(<2-fold change, yellow) in transcript levels be-
tween embryonic hepatoblasts and adult liver.
(B) RNA-seq profiles of the top-ranking differen-
tially expressed genes (H19 and Serpina3k) in
embryonic (green) and adult (blue) liver.
(C) GO analysis of differentially expressed tran-
scripts in embryonic (green) and adult (blue) liver.
(D) Global expression levels in embryonic (green)
and adult (blue) liver of putative target genes
associated with HNF4A and FOXA2 in the embryo
only (left), embryonic and adult liver (continuous,
middle), or adult only (right). The NAC is the
cumulative base coverage of a feature normalized
to feature length and library size. Significance
was tested using Kruskal-Wallis one-way ANOVA
with Dunn’s post-test correction; ****p < 0.001,
***p < 0.005. Error bars in the boxplot represent
minimum to maximum values.
(E) In the upper panel, relative expression levels
(log10) of genes targeted by HNF4A and FOXA2 in
a differentiation-dependent manner are ranked
as either embryo-enriched (green) or adult liver-
enriched (blue). Intensity in bottom two heatmaps
(black, low; yellow, high) reflects the average
number of differentiation-dependent DNA-binding
sites within associated enhancer promoter unit
divided by the average number of sites in an EPU
included in the analysis (see also Figure S4).
(F) Genes were categorized according to the
associated number of differentiation-dependent
enhancers and global gene expression levels were
compared between those not bound specifically
at the developmental stage indicated, targeted at
one or two putative enhancers or bound at more
than two sites. Significance was tested using
Kruskal-Wallis one-way ANOVA with Dunn’s post-
test correction; ****p < 0.001. Error bars in the
boxplot represent minimum to maximum values.
See also Table S2.we carried out a GO analysis (Eden et al., 2009). As anticipated,
‘‘cell cycle’’ was significantly enriched in proliferating embryonic
hepatoblasts, whereas pathways including ‘‘oxidation reduc-
tion’’ and ‘‘metabolic process’’ dominated the transcriptome of
mature hepatocytes. Interestingly, embryonic samples were
also significantly enriched for transcripts associated with cell
component organization, adhesion, and differentiation (Fig-
ure 4C). In contrast to previous studies by Kyrmizi et al. (2006),
we did not observe statistically significant differential expression
of Hnf4a and Foxa2 transcript levels during liver maturation. This
is likely because they used whole embryonic livers, whereas we
used isolated hepatoblasts. Furthermore, we detected only
minor contributions from the Hnf4a P2 promoter (Figure S4;
Torres-Padilla et al., 2001).To explore how differentiation-dependent HNF4A and FOXA2
cobinding may affect temporal gene-expression patterns during
hepatoblast maturation, we examined the expression level of
putative target genes. Genes associated with ‘‘Embryonic’’
enhancers (cobound by HNF4A and FOXA2 in the embryo)
exhibited a significant global decrease in expression during
development, whereas expression of genes targeted by ‘‘Adult’’
enhancers (cobound by HNF4A and FOXA2 in the adult) showed
a significant increase in the adult liver (p < 0.001 and p < 0.01,
respectively). No significant change in continuously targeted
genes was detected (Figure 4D).
Gene transcription is often influenced by TF occupancy at
multiple enhancer regions (Ong and Corces, 2011). For example,
Afp associates with a number of sites occupied by HNF4A andCell Reports 9, 261–271, October 9, 2014 ª2014 The Authors 265
Figure 5. TEAD2 Cooperates with HNF4A and FOXA2 at Developmentally Regulated Embryonic Enhancers
(A) Anchored combination site analysis using oPOSSUM. Motifs of expressed TFs enriched at embryonic enhancer regions were graphed according to Fisher
and Z score values.
(B) Composite position-weighted matrix of all identified TEAD1 motifs at embryonic enhancer regions, generated using STAMP.
(C) Heatmap depicting NAC values for TEAD family members (red, high; green, low) in RNA-seq libraries made from DLK1+ hepatoblasts (Embryo) and adult
liver (Adult).
(D) Read density histogram proximal to the Tead2 locus, displaying HNF4A binding in embryonic hepatoblasts (green), but not in adult hepatocytes (blue).
(E) Western blot analysis of protein isolated from embryonic (E14.5) and adult liver using anti-Tead2 and anti-actb.
(F) Nuclear extracts were isolated from 293T cells expressing myc-tagged TF or from E14.5 liver and incubated with P32-labeled probes containing TF-binding
motifs found at the enhancer region associated with Sall4 and 3 mg of anti-myc (top panel), anti-HNF4A, or anti-TEAD2. Note that a shift (denoted by a black
bar and ‘‘S’’) was detected with both probes and in both 293T and E14.5 extracts. A supershift (denoted by a black bar and ‘‘SS’’) was detected using anti-myc
and anti-HNF4A (due to the poor quality of the antibody, no supershift to endogenous protein could be detected using anti-TEAD2).
(legend continued on next page)
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FOXA2 exclusively in the embryo in which it is highly expressed.
To test for a relationship between the number of differentiation-
dependent TF sites and differential gene-expression levels, we
ranked expressed target genes by fold enrichment, from the
highest in adult liver (blue) to the highest levels in embryonic liver
(green) (Figure 4E; top heatmap). We calculated the number of
differentiation-dependent binding sites (embryo, middle; adult,
bottom) within corresponding gene regions and found that
temporally expressed target genes were more highly associated
with differentiation-dependent enhancers. Furthermore, when
we applied a statistical analysis to this relationship, we deter-
mined that association with one or more differentiation-depen-
dent binding sites is predictive of higher gene-expression levels
at the appropriate developmental stage (p% 0.001), suggesting
that dynamic HNF4A and FOXA2 DNA binding influences the
evolving hepatoblast-hepatocyte transcriptome during matura-
tion. This association was also true for peaks occupied by
HNF4A alone (Figure S4).
Motif Analysis of Temporal Enhancers Reveals
an Embryonic-Specific Cofactor
Having demonstrated that HNF4A and FOXA2 bind to functional
enhancer regions in a differentiation-dependent manner to
regulate temporal gene-expression patterns, we investigated
potential mechanisms underlying this enhancer-switching
behavior. Previous studies suggested that local sequence con-
servation or motif affinity may influence the stability of TF binding
in different tissues or conditions. Consequently, we compared
sequences underlying sites co-occupied by HNF4A and FOXA2
at different stages of development. We found no strong
differences in either sequence conservation or the underlying
HNF4A or FOXA2 motifs between sites bound in a differentia-
tion-dependent manner (Figure S5).
Although HNF4A and FOXA2 motifs were indistinguishable by
our analysis, the enrichment or depletion of other TF bindingmay
influence DNA accessibility and/or occupancy during develop-
ment. Interestingly, we found that the motif related to the nuclear
receptor FXR, which is more highly expressed in the adult, was
enriched at adult specific sites (data not shown). However, we
chose to focus on identifying TF motifs that underlie embryonic
peaks, since many cofactors in the adult liver are already well
established but comparatively little is known about the embry-
onic liver. To isolate differentially enriched motifs, we employed
the motif-finding algorithm oPOSSUM (http://opossum.cisreg.
ca/oPOSSUM3/). We examined embryonic-specific enhancer
regions using adult-specific enhancers as a background data
set (Subramanian et al., 2014). Reassuringly, our analysis de-
tected TFs such as HNF1a, HNF1b, and CEBPa, which are
known to work with HNF4A and FOXA2 during liver development
(Figure 5A). FOXA2 was also among our candidates because
embryonic enhancers showed a greater number of underlying
FOXA2 motifs than adult-specific enhancers (Figure S5). Intrigu-(G) Embryonic enhancers containing TEAD motifs were cloned into luciferase v
alongside a Renilla-containing construct. Expression vectors for HNF4A, FOXA2, T
YAP (S94A YAP1) were cotransfected in different combinations. Luciferase ass
experiments are represented as mean ± SEM.
See also Figure S5.ingly, the TEAD1 motif was enriched. TEAD transcriptional activ-
ity is dependent on interactions with YAP1, a downstream
component of the Hippo signaling cascade. This pathway con-
trols liver size and is commonly amplified in human hepatocellu-
lar carcinoma (Camargo et al., 2007; Zender et al., 2006). We
determined the quality of predicted TEAD1 motifs by generating
a composite of all TEAD1 motifs at embryonic enhancer regions
(Figure 5B). Since TEAD motifs are similar among family mem-
bers, we verified the transcript levels of all four family members
in embryonic and adult liver (Figure 5C). Tead2 was the most
highly expressed family member in embryonic liver, being ex-
pressed at a level similar to that observed for Foxa2, and was
the most dramatically downregulated in adult liver. Interestingly,
the Tead2 locus itself is targeted by HNF4A in a developmentally
regulated manner, highlighting a possible cofactor feedback
mechanism (Figure 5D). TEAD2 protein was robustly detected
in embryonic liver and its levels were decreased in adult liver
(Figure 5E). Moreover, using an electrophoretic mobility shift
assay (EMSA), we verified that TEAD2 can interact with pre-
dicted sites (such as the Sall4 locus). We detected binding of
both HNF4A and TEAD2 upon incubation with nuclear extract
isolated from 293T cells expressing MYC-tagged TFs and nu-
clear extracts from E14.5 livers.
To determine whether TEAD binding can influence target gene
expression, we cloned a selection of embryonic-specific en-
hancers into luciferase vectors. We observed limited activity
when luciferase vectors containing no enhancer region (E1B pro-
moter only) or the adult-specific enhancer for Serpina3K were
cotransfected with TEAD2 and YAP1 expression plasmids (Fig-
ure 5G). However, enhancer regions predicted to contain TEAD
motifs (associated with H19, Dlk1, and Sall4 genes) produced
a >2-fold induction of activity in the presence of TEAD2 and
YAP1 expression. Similar levels of induction were observed
(2-fold) when HNF4A and FOXA2 were expressed. However,
when all four factors were expressed, a >10-fold increase in
enhancer activity was detected. The additive effect was dimin-
ished when a dominant-negative version of HNF4A or TEAD2
was substituted. A similar reduction was also seen upon addition
of YAP S94A mutant (Hong et al., 2003). Interestingly, the
enhancer associated with Sall4 showed a more robust response
to TEAD2 and YAP1 than to HN4A and FOXA2, suggesting that it
is highly dependent on Hippo signaling. Together, these data
support a model in which TEAD2 and YAP1 can promote the
expression of genes associated with a subset of HNF4A/
FOXA2 embryonic enhancer regions.
To determine whether the presence of TEAD2 and YAP1 can
influence HNF4A and FOXA2 recruitment to differentiation-
dependent enhancers in vivo, we used an inducible transgenic
mousemodel in which YAP1 is expressed in the liver in response
to doxycycline (Figure S6; Dong et al., 2007). After 2 weeks of
treatment, we conducted a ChIP-qPCR analysis of HNF4A and
FOXA2 in livers of transgenic mice and age-matched controlsectors containing a minimal promoter (E1B) and transfected into 293T cells
EAD2, YAP1, dominant-negative HNF4A (DN-HNF4A), DN-TEAD2, andmutant
ays were conducted 48 hr after transfection. Data shown are from duplicate
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Figure 6. Ectopic Expression of YAP1 in Adult Liver Induces Changes in HNF4A- and FOXA2-DNA Binding
ChIP-qPCR analysis of HNF4A (top panel) and FOXA2 (lower panel) in control (white) and YAP-induced (gray) adult liver.
(A) TF enrichment is expressed as fold over control immunoprecipitation (normal rabbit IgG). The gray bar indicates regions previously shown to be bound in both
embryonic and adult liver (AFP enh2, HNF4a, and TRF). Neg1 and Neg2 function as negative control regions in which no enrichment was expected. Afp enh3,
Gpc3,H19,Sall4, andDlk1 (green bar) represent regions previously shown to be exclusively occupied in embryonic liver. Ido2,Agxt, Igf1,Prlr, andNnmt (blue bar)
represent regions previously shown to be exclusively occupied in adult liver. Data are represented as mean ± SEM from triplicate experiments. Multiple t tests
were conducted to determine significance (*p < 0.05).
(B) ChIP-PCR analysis represented as fold change between control = 1 and YAP-induced liver.(Figure 6A). We observed no changes in HNF4A and FOXA2
occupancy at sites occupied in both embryonic and adult liver
(Afp enh2, Hnf4a, and Trf). At embryonic enhancer sites, we
noted a small but significant increase (e.g., FOXA2 at Afp enh3
and HNF4A at Sall4; p % 0.05). However, detection of HNF4A
and FOXA2 occupancy notably decreased at the adult-specific
enhancers Ido2 and Prlr (p % 0.05) upon ectopic expression of
YAP1. Consistent with a previously published microarray anal-
ysis of YAP-TG-induced livers (Dong et al., 2007), the expression
levels of a number of genes associated with embryonic liver,
including Dlk1, H19, and Afp, increased after YAP1 induction.
However, we also noted a decrease in the expression of adult
targets, including Ido2 and Nnmt. Figure 6B illustrates the fold
change in enhancer occupancy detected by ChIP-qPCR after
induction of YAP1. Together, these results suggest that the
presence of YAP1 in the nucleus influences HNF4A and FOXA2
binding-site choice and target gene expression.
DISCUSSION
Here, we document how lineage-specifying TFs that are present
in the nucleus throughout the differentiation process can
contribute to the evolving transcriptomes of mammalian cells
undergoing maturation in vivo. Using RNA-seq and ChIP-seq268 Cell Reports 9, 261–271, October 9, 2014 ª2014 The Authorslibraries generated from embryonic hepatoblasts and adult
liver, we have shown that the key hepatic TFs HNF4A and
FOXA2 occupy enhancers and control target gene expression
in a differentiation-dependent manner. Furthermore, we highlight
how Hippo signaling influences HNF4A and FOXA2 enhancer
switching, thereby affecting target gene expression and the
status of hepatocyte differentiation.
It is notoriously difficult to propagate or even maintain hepato-
cytes in a functional differentiated state in vitro. Investigators
have achieved partial success by developing 3D tissue culture
models and using a multitude of extracellular matrix (ECM)
components in the form of Matrigel (Raju et al., 2013). TEAD2
functions as a nuclear TF in the Hippo signaling pathway,
which can regulate cell death, proliferation, and differentiation
(reviewed in Yu and Guan, 2013). In the absence of Hippo
pathway activity (e.g., at low cell density), YAP1 is shuttled to
the nucleus, which enhances the ability of TEAD2 to induce
target gene expression (Schlegelmilch et al., 2011). We propose
a model in which reduced cell densities and disrupted cell-cell
and cell-ECM contacts, all of which are required for in vitro
propagation, likely cause nuclear localization of YAP1, which
in turn influences HNF4A and FOXA2 binding-site choice.
Consequently, genes associated with embryonic liver are acti-
vated and the expression levels of genes associated with fully
differentiated, functional hepatocytes decline. Although the
Hippo signaling cascade has previously been implicated in
regulation of liver size and cancer development, only very recent
studies using a mosaic YAP1 induction model have shown that
nuclear YAP1 is able to induce hepatocyte dedifferentiation
into clonogenic progenitors in vivo (Yimlamai et al., 2014).
Our work further implicates Hippo signaling in hepatocyte
differentiation.
Due to the difficulty of propagating hepatocytes in vitro,
HEPG2, a hepatocellular carcinoma (HCC) cell line, is commonly
used to represent hepatocytes. Interestingly, the ENCODE Pro-
ject has conducted ChIP-seq to examine HNF4A and TEAD4
in HEPG2 cells (https://www.encodeproject.org/experiments/
ENCSR000BRP/). Remarkably, 45% of TEAD4 binding sites
overlap by at least 50 bp with HNF4A sites. Furthermore en-
hancers co-occupied by HNF4A and TEAD4 in HEPG2 cells
were found at ‘‘embryonic’’ target genes, such as Sall4 and
Dlk1, suggesting that the synergy we uncovered between
TEAD2 and HNF4A could also be applicable to human liver
development and HCC. The embryonic target gene Sall4 high-
lighted in our analysis is of particular interest because forced
expression has been shown to inhibit hepatoblast differentiation
along the hepatocyte lineage, whereas downregulation encour-
ages bile duct formation (Oikawa et al., 2009). Furthermore,
Sall4 was recently identified as a ‘‘targetable marker’’ for an
aggressive subset of HCC (Yong et al., 2013).
HNF4A has previously been implicated in regulating tissue
remodeling, which is required for normal liver formation. Ablation
of HNF4A specifically in the embryonic liver causes loss of
cohesive tissue architecture with disruption of cell-cell junction
assembly (Battle et al., 2006; Parviz et al., 2003). In this work,
we noted that members of the Focal Adhesion Kinase pathway
featured prominently among the temporally expressed, embry-
onic-specific HNF4A target genes. Furthermore, a previous
gene-expression analysis of postnatal heterozygous YAP mice
indicated that ECM proteins become deregulated (Septer
et al., 2012). Together, these studies suggest that significant
crosstalk occurs between the hepatoblast microenvironment
and HNF4A to regulate enhancer binding, target gene expres-
sion, and liver maturation.
Recent studies have examined the phenomenon of enhancer
switching by master regulators using in vitro models of dif-
ferentiation. For example, the pluripotency-associated pioneer
factor OCT4 dramatically switches enhancers upon transition
from an embryonic stem cell to an epiblast-like cell state
(Buecker et al., 2014). Soleimani et al. (2012) showed that
MYOD, a TF that is well known to induce muscle cell fate,
can change binding sites between primary myoblast and
induced myotube states. In contrast to our analysis, they
demonstrated that subtle differences in motifs underlying dif-
ferentiation-dependent sites enable competitive binding of a
repressive TF. Temporal expression of a repressive factor
may also explain why HNF4A and FOXA2 are unable to bind
adult sites in the embryonic liver. Although we have found no
evidence of this to date, it is possible that induction of YAP1
leads to activation of a repressive factor that can mask adult
enhancer regions in the embryonic liver, thereby preventing
premature differentiation.In summary, our results highlight that lineage-specifying TFs
undergo widespread enhancer switching during in vivo cell dif-
ferentiation and organ development, which enables these key
players to perform distinct yet important roles in both progenitor
and mature cell populations. The data generated by this inves-
tigation into TF binding behaviors offer a rich resource that will
continue to facilitate a greater understanding of both transcrip-
tional regulation and hepatocyte differentiation.
EXPERIMENTAL PROCEDURES
Animals
C57BL6/J and ApoE-rtTA;TRE-hYAP transgenic mice (Dong et al., 2007) were
cared for under protocols approved by the Animal Care Committee of the
University of British Columbia or the Johns Hopkins University IACUC. Three
transgenic and three wild-type female mice (4 weeks old) were given a dose
of 0.2 mg/ml doxycycline in drinking water for 2 weeks. Livers from these
mice were flash-frozen before qRT-PCR, western blotting, and ChIP-qPCR
analysis were performed.
Purification of Fetal Hepatoblasts
Embryonic livers collected at E14.5 were incubated in 0.005% collagenase
type I (STEMCELL Technologies), 0.05 U/ml dispase, 1 mM EDTA, and 10%
fetal bovine serum for 40min on a shaker at 215 rpm 37C, and then incubated
on ice for 10 min with 6 mg FITC-conjugated, anti-DLK1 (D187-4; MBL Interna-
tional). Cells weremagnetically separated using the EasySep FITC selection kit
(STEMCELL Technologies). For RNA-seq, enriched populations were purified
by fluorescence-activated cell sorting.
ChIP-Seq and RNA-Seq
Perfused female adult liver or embryonic hepatoblasts were fixed prior to cell
sorting in 1% formaldehyde for 10 min or 45 min (embryonic HNF4A ChIP
only). ChIPwas performed as described previously (Wederell et al., 2008) using
3 mg of anti-FOXA2 (Santa Cruz sc-6554), anti-HNF4A (Santa Cruz sc-8987),
anti-H3K4me1 (Abcam ab8895), anti-H3K27me3 (Abcam Ab8580), anti-
H3K9me3 (Abcam), or normal rabbit IgG (Santa Cruz). DNA was purified by
8% PAGE to obtain 100–300 bp fragments for library construction and
sequenced on an Illumina Genome Analyzer as previously described (Robert-
son et al., 2007). Reads were aligned to the mouse reference genome (mm9)
using ELAND and directionally extending to 200 bp in length. Clusters of over-
lapping extended reads were defined as enriched regions using FindPeaks2
(Fejes et al., 2008). Thedata setswere limitedby applying thresholds asdefined
by an FDR cutoff of 0.01 and by trimming at 20% of maximal height to remove
flanks and separate composite regions (Fejes et al., 2008). Input control
samples (hepatoblasts and adult liver) were sequenced and analyzed using
similar limits. Any regions of enrichment identified in input control samples
were subtracted from the data sets. For RNA-seq analysis, RNA was prepared
using TRIzol (Invitrogen) and sequenced on an Illumina Genome Analyzer as
previously described (Griffith et al., 2010). The following NCBI data sets were
used in this study: SRA008281, GSM751034, and GSM751035 (Hoffman
et al., 2010; Tennant et al., 2013). Unthresholded TF ChIP-seq data can be
visualized in the UCSC Genome Browser using the following URLs.
bigDataUrl=http://www.bcgsc.ca/downloads/Hoodless_2014/FoxA2_E14_
mm9.bw
bigDataUrl=http://www.bcgsc.ca/downloads/Hoodless_2014/Hnf4a_E14_
mm9.bw
bigDataUrl=http://seqweb.bcgsc.ca/downloads/Hoodless_2014/FoxA2_
adult_mm9.bw
bigDataUrl=http://www.bcgsc.ca/downloads/Hoodless_2014/Hnf4a_adult_
mm9.bw
Bioinformatic Analysis
Regions of enrichment (peaks) defined by ChIP-seq analysis were designated
as overlapping if >50 bp were shared. Data set comparisons were carried outCell Reports 9, 261–271, October 9, 2014 ª2014 The Authors 269
using publically available Galaxy/Cistrome metaservers (Blankenberg et al.,
2010; Goecks et al., 2010). CEAS was used to assess genomic distributions,
SitePro (Shin et al., 2009) generated the composite histone modification
profiles, and HNF4A and FOXA2 motif analysis was done using SeqPos
(He et al., 2010). Heatmaps were generated using MeV (http://www.tm4.org/
mev.html). Differential motif discovery was done using oPOSSUM (http://
opossum.cisreg.ca/oPOSSUM3/) sequence-based anchored combination
site analysis (Subramanian et al., 2014). Enriched motifs were identified in
co-occupied embryonic sites using GC% matched co-occupied adult sites
as background and an anchored HNF4A JASPAR CORE profile with a matrix
match threshold of 85%. TF-binding sites were associated with target genes
using previously established enhancer promoter units (Shen et al., 2012).
RNA-seq analysis was carried out using the publically available ALEXA-seq
pipeline (Griffith et al., 2010). Briefly, the cumulative base coverage of a feature
was normalized to the feature length and library size, giving the ‘‘normalized
average coverage’’ (NAC). Transcripts were considered differentially ex-
pressed if NAC values differed by a factor of 2 and their corrected p value
was <0.05 (by Fisher’s exact test). Data sets are accessible at http://www.
alexaplatform.org/alexa_seq/Morgen/Summary.htm.
Cell Culture Assays
HNF4A and HNF4A DN expression vectors were provided by T. Leff (Hong
et al., 2003). TEAD2 and YAP1 expression vectors were provided by J.F. Mar-
tin (Heallen et al., 2011). TEADDN and YAP S94A expression vectors were pre-
viously described (Shen et al., 2012). Enhancer regions were PCR amplified
and cloned into a PGL3 basic vector containing the E1B minimal promoter.
TK-Renilla controlled for transfection efficiency. HEK293T were maintained
in Dulbecco’s modified Eagle’s medium containing 10% fetal bovine serum.
Transfections were performed using PEI (Raju et al., 2013). Firefly and Renilla
activity was measured with a Dual Luciferase Reporter Assay kit (Promega)
and presented as the Firefly/Renilla ratio. Western blot analysis was carried
out on nuclear extracts from pooled embryonic livers (E14.5) and female adult
liver using anti-YAP1 (Cell Signaling), anti-TEF4 (Tead2; Novus Biologicals),
and anti-beta actin (Santa Cruz). Nuclear extracts for EMSAs were prepared
from 293T cells transfected with TEAD-myc/HNF4-myc or E14.5 as previously
described (Labbe´ et al., 1998).
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